ruxolitinib,navtemadlin
incyte,kartos therapeutics,novartis
['mpnsm', '#mpn', 'navtemadlin', 'rux,(-crux),(-trux),(-deruxtecan)', 'ruxolitinib', 'rux,(-crux),(-trux)']
navtemadlin elicits spleen volume reduction when added to stable ruxolitinib in patients with myleofibrosis #eha2023 #mpnsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.